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Neurological disorders are prevalent worldwide. Cerebrovascular diseases (CVDs), which
account for 55% of all neurological diseases, are the leading cause of permanent
disability, cognitive and motor disorders and dementia. Stroke affects the function and
structure of blood-brain barrier, the loss of cerebral blood flow regulation, oxidative stress,
inflammation and the loss of neural connections. Currently, no gold standard treatments
are available outside the acute therapeutic window to improve outcome in stroke patients.
Some promising candidate targets have been identified for the improvement of long-
term recovery after stroke, such as Rho GTPases, cell adhesion proteins, kinases,
and phosphatases. Previous studies by our lab indicated that Rho GTPases (Rac and
RhoA) are involved in both tissue damage and survival, as these proteins are essential
for the morphology and movement of neurons, astrocytes and endothelial cells, thus
playing a critical role in the balance between cell survival and death. Treatment with a
pharmacological inhibitor of RhoA/ROCK blocks the activation of the neurodegeneration
cascade. In addition, Rac and synaptic adhesion proteins (p120 catenin and N-catenin)
play critical roles in protection against cerebral infarction and in recovery by supporting
the neurovascular unit and cytoskeletal remodeling activity to maintain the integrity of
the brain parenchyma. Interestingly, neuroprotective agents, such as atorvastatin, and
CDK5 silencing after cerebral ischemia and in a glutamate-induced excitotoxicity model
may act on the same cellular effectors to recover neurovascular unit integrity. Therefore,
future efforts must focus on individually targeting the structural and functional roles of
each effector of neurovascular unit and the interactions in neural and non-neural cells in
the post-ischemic brain and address how to promote the recovery or prevent the loss of
homeostasis in the short, medium and long term.
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INTRODUCTION
Neurological disorders are highly prevalent around the globe.
In 2008, neurodegenerative disorders were responsible for 1%
of disabilities worldwide (W.H.O., 2003). Strokes account for
55% of all neurological diseases and are considered the lead-
ing cause of permanent physical and mental disability (OMS,
2013). The primary risk factors of stroke include hyperlipidemia,
hypertension, diabetes mellitus, and harmful habits, such as
smoking and excessive alcohol consumption. The high incidence
of strokes is related to an increased number of dementia cases
and other emotional and cognitive disorders, such as depres-
sion and memory loss (Ovbiagele and Nguyen-Huynh, 2011).
Death, physical deterioration, and altered quality of life are
consequences of the natural history of strokes among patients
who survive an ischemic event (Sacco, 1997, 1998; Feigin et al.,
2003; Silva et al., 2006). Interestingly, the coexistence of cerebral
ischemia and neurodegenerative pathologies profoundly impacts
the development of dementia, suggesting a reciprocal interaction
between ischemia and neurodegeneration (Nagy et al., 1997;
Snowdon et al., 1997). These observations, along with the results
of epidemiological studies that have indicated that Alzheimer’s
disease (AD) and cerebrovascular diseases share similar risk fac-
tors (Breteler, 2000), have shifted interest to vascular factors
as fundamental contributors to the pathogenesis of neurode-
generative diseases (de la Torre and Mussivand, 1993; Kalaria,
2000; Iadecola and Gorelick, 2003). This hypothesis has been
supported by the experimental findings that showed that amyloid-
beta (Aβ) peptide, which is commonly detected in AD patients,
exhibits strong cerebrovascular effects and that ischemia-induced
responses to hypoxia are potent modulators of cerebral amyloido-
genesis (Iadecola, 2004). Both Aβ peptide and vascular risk factors
deteriorate the structure and function of the neurovascular unit
(NVU, consisting of the endothelium, glia, neurons, pericytes,
and the basal lamina) (Mirra and Gearing, 1997; Snowdon et al.,
1997; Breteler, 2000; Kalaria, 2000; Iadecola and Gorelick, 2003;
Iadecola, 2004).
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The NVU acts as a guardian of cerebral homeostasis. Neurons,
glia, the perivascular space, and the endothelium are closely
interrelated to maintain the homeostasis of the brain microen-
vironment (Iadecola, 2010), regulate blood flow, modulate the
exchange across the blood-brain barrier (BBB), contribute to
immune vigilance and provide trophic support to the brain
(Iadecola, 2010). Substantial evidence has shown that cerebrovas-
cular dysfunction is implicated in not only cognitive impairment
(such as that of cognitive origin) but also neurodegenerative
diseases, such as AD (Chui et al., 1992; Alavi et al., 1998; Kalaria,
2000; Iadecola, 2004; Simpkins et al., 2005; Hachinski et al., 2006;
Pendlebury et al., 2012). Ischemic stroke is exacerbated by several
risk factors that affect the function and structure of blood vessels
in the brain and cells associated with the NVU, reducing the
ability of the brain parenchyma to repair due to the rupture of
the BBB, the loss of brain blood flow regulation, oxidative stress,
inflammation, and the loss of neuronal connections, ultimately
increasing brain dysfunction (Deane et al., 2003; Ohab et al., 2006;
Konsman et al., 2007; Weber et al., 2007; Bell et al., 2009; Wolburg
et al., 2009). The study of stroke has focused on understanding the
molecular and pathophysiological mechanisms of neuronal death,
recovery and pharmacological intervention strategies, as well as
clinical and epidemiological characteristics (Silva et al., 2006).
In addition, several molecular targets associated with endothelial
dysfunction and cardio-cerebrovascular risk, including CDK5,
Rho GTPases, and cell adhesion proteins, are described below and
presented in a hypothetical schematic in Figure 1 to explain and
propose a potential neuroprotective approach for stroke.
CEREBRAL ISCHEMIA
Cerebral ischemia is a type of stroke characterized by a transient
or permanent decrease in blood flow as a result of the thrombotic
or embolic occlusion of one or more cerebral arteries. Depending
on the ischemic characteristics (i.e., the duration of reduced blood
flow and the infarction site), this disease can result in several
clinical manifestations, including paralysis or hemiplegia, aphasia,
and memory and learning impairment, among others (Kemp and
Mckernan, 2002).
In focal cerebral ischemia, a hypoperfusion gradient is gen-
erated, leading to the activation of diverse cell types involved
in survival and cell death mechanisms (Lipton, 1999; Barreto
et al., 2011, 2012). Within minutes after ischemia, the acti-
vated microglia induces cytokine and adhesion molecules; hours
to days, the endothelium responds by increasing angiogenesis;
in days, weeks to months, astrocytes expressing GFAP (glial-
fibrillary acidic protein) generate glial scar; and the neurons trig-
ger axonal sprouting, dendrite outgrowth, spine morphogenesis
(Iadecola, 1997; Rami et al., 2008; Barreto et al., 2012). The region
suffering the most severe degree of hypoperfusion, referred to as
the ischemic core, progresses rapidly toward irreversible damage
via necrosis. The remaining hypoperfused tissue displays altered
mechanisms of blood flow autoregulation and is known as the
penumbra (Baron, 2001; Moustafa and Baron, 2008). In this peri-
infarct zone, neurons display functional alterations and minimal
metabolic activity to preserve their structure, but these neurons
ultimately advance toward apoptotic death (Mies et al., 1993;
Moskowitz et al., 2010). Accordingly, the penumbra is not only a
functionally affected tissue but is also potentially recoverable and,
as such, represents a key target for therapeutic intervention for
cerebral ischemia (Baron et al., 1995). However, unless perfusion
is restored or the cells surrounding the injury site become rela-
tively resistant, the cells in the penumbra die via apoptosis within
a few hours (Lo, 2008b).
An interruption in the blood supply to the brain during
ischemia results in oxygen-glucose deprivation and, consequently,
reduced energy available for brain cell functions (Dingledine
et al., 1999). In particular, neurons become incapable of main-
taining the transmembrane ion gradients necessary for their func-
tion and homeostasis (Szydlowska and Tymianski, 2010). This
event leads to excessive neuronal depolarization, an increase in
the release of excitatory neurotransmitters and pro-inflammatory
molecules, a reduction in the reuptake of these neurotransmitters
from the extracellular space in penumbra and a GABAergic and
dopaminergic misbalance in exo-focal areas (Sabogal et al., 2014).
Altogether, these pathological mechanisms induce an excessive
intracellular accumulation of ions such as Na+ and Ca2+ and,
simultaneously, the deregulation of multiple signaling pathways,
activating catabolic processes mediated by proteases, lipases, and
nucleases, which interrupt neuronal function and induce cell
death (Dingledine et al., 1999; Szydlowska and Tymianski, 2010;
Barreto et al., 2011). Increased extracellular glutamate concen-
trations in central nervous system (CNS) pathologies (including
stroke, epilepsy and certain neurodegenerative diseases) result
in the local hyperactivation of ionotropic glutamate receptors,
thereby triggering neuronal cell death via excessive Na+ and
Ca2+ influx into neurons (Olney, 1969; Choi, 1987; Sattler and
Tymianski, 2001; Greenwood and Connolly, 2007). This event
is known as glutamate-mediated excitotoxicity (Lipton, 1999;
Mehta et al., 2007). In the core, glutamate excitotoxicity rapidly
evolves to necrosis due to ATP depletion and increased Na+ and
water influx, whilst in the penumbra, where the damage seems
to be less severe, glutamate excitotoxicity produces neuronal
apoptosis (Bonfoco et al., 1995; Kelly et al., 2003; Lo, 2008a;
Rami et al., 2008). Glutamate-induced dendritotoxicity results in
microtubule disruption and the calcium-dependent loss of MAP2
and contributes to dendritic dysfunction in acute hippocampal
slices (Bindokas and Miller, 1995; Hoskison and Shuttleworth,
2006; Hoskison et al., 2007) and nearly complete dendritic loss in
cortical neuron cultures (Bosel et al., 2005; Ma et al., 2009). Toxic
cytoplasmic calcium concentrations during ischemia can occur
due to the release of calcium from internal stores via physical
damage to the mitochondria and endoplasmic reticulum (ER)
or the malfunction of receptors and channels present in their
membranes (Loew et al., 1994; Paschen and Doutheil, 1999). The
accumulation of intramitochondrial Ca2+ reduces ATP synthesis,
and increased ATP usage has been suggested to be a primary
cause of cell death (Schinder et al., 1996). The dysregulation of
Ca2+-ER homeostasis following ischemia involves two phases: the
accumulation of Ca2+ in ER stores and the subsequent release
of Ca2+ from the ER following ischemia/reoxygenation (Chen
et al., 2008). It has been suggested that Ca2+ released from the
ER via IP3R can enter the adjacent mitochondria and trigger
cytochrome c release (Rizzuto and Pozzan, 2006). The increase
in the cytoplasmic calcium concentration triggers neurotoxic
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FIGURE 1 | NVU in cerebral ischemia includes a closely coupled signaling
network of ECs, pericytes, astrocytes and neurons. Neurovascular
uncoupling consists of the expression of various cytokines and adhesion
molecules on ECs, promoting leukocyte adherence and accumulation, which
thereby initiates an inflammatory response. Further, breakdown of the BBB
via NO, MMPs and ROS permits neutrophil extravasation into the ischemic
tissue in response to chemokines produced by astrocytes, macrophages, and
microglia. Glutamate-mediated excitotoxicity via NMDA and AMPA receptors
induces the hyperstimulation of neurons and subsequent calcium influx,
indicating several intracellular calcium stores (mitochondria and ER), which
triggers dendritotoxic and cell death pathways. Intrinsic neurovascular
responses after stroke are triggered by astrocytes via the spread of calcium
waves, promoting homeostatic gliotransmission. In addition, glutamate
uptake by astrocytes, which requires EAATs, represents the primary
neuroprotective response after excitotoxicity. Alternatively, K+ and glucose
uptake and insulin and albumin transport signal the modulation of
neurovascular homeostasis. Tight junctions (TJs) consisting of claudins,
occludins and JAM and adherens junctions (AJ) including members of the
cadherin-catenin system maintain the integrity of the endothelium. Cell–cell
adhesion may transmit intracellular signals that regulate paracellular
permeability, contact-induced inhibition of cell growth and new vessel
formation. After stroke, pericytes display deformed junctions and increased
formation of pinocytic vesicles, which affect the polarization of astrocyte
end-feet (AF), detected as the defective deposition of the astrocyte-derived
basement membrane (aBM). Deposition of the endothelium-derived
basement membrane (eBM) is affected by the lack of pericytes. Moreover,
modifications of the molecular organization and intracellular signaling of
junction proteins may exert complex effects on vascular homeostasis.
cascades, including the uncoupling of mitochondrial electron
transfer from ATP synthesis and the activation and hyperstimu-
lation of enzymes, such as calpains and other proteases, protein
kinases, neuronal nitric oxide synthase (nNOS), calcineurin and
endonucleases (Szydlowska and Tymianski, 2010).
In recent studies, we found that glutamate-mediated exci-
totoxicity decreases the number and length of dendrites and
induces tau hyperphosphorylation (Posada-Duque et al., 2013).
The hyperphosphorylation of tau, a neurodegeneration marker,
is also increased by global and transient focal cerebral ischemia,
causing alterations in spatial memory (Castro-Alvarez et al., 2011;
Céspedes et al., 2013). At the cellular level, hyperactivated GSK3
protein is associated with alterations in microtubule assembly,
and the activity of RhoA has been associated with the retraction
of the actin cytoskeleton (Céspedes-Rubio et al., 2010). Damage
to the neuronal cytoskeleton can be considered the primary cause
of the loss of protein transport and neuronal stability in cerebral
ischemia. Microtubule disassembly occurs after ischemia and
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plays an important role in the pathophysiology of this disease
(Pettigrew et al., 1996). Alterations in the cytoskeleton reflect, in
part, processes of protein degradation and aggregation following
ischemia (Kühn et al., 2005). For example, we found that the
loss of Rac activity participates in the progression of cerebral
ischemia-induced neurodegeneration and is closely associated
with cognitive disorders (Gutiérrez-Vargas et al., 2010). In addi-
tion, MAP2 degradation and tau aggregation and hyperphospho-
rylation are considered biomarkers of ischemic damage (Pettigrew
et al., 1996; Gutiérrez-Vargas et al., 2010).
NVU: THE GUARDIAN OF CEREBRAL HOMEOSTASIS
The BBB is a highly specialized endothelial brain structure com-
posed of a specialized neurovascular system. Through pericytes,
astrocytes, and microglia, the BBB separates components in
circulating blood from neurons. Moreover, the BBB maintains
the chemical composition of sodium, anion carbonate, glucose,
lactate, essential amino acids, insulin, enkephalins, and arginine-
vasopressin, which is required for the proper function of neuronal
circuits in the adult brain (Zlokovic, 2008). The endothelium,
the site of the anatomical BBB, neurons, and non-neuronal cells
(e.g., pericytes, astrocytes, and microglia) together with the basal
lamina form a functional unit, often referred to as the NVU, which
participates in the establishment and function of the BBB (Lo
et al., 2003; Hawkins and Davis, 2005). Cerebral endothelial cells
(ECs) significantly differ from non-cerebral ECs in the following
aspects: (i) the presence of intercellular tight junctions (TJs); (ii)
low levels of transcytosis (pinocytosis) and paracellular diffusion
of hydrophilic compounds; (iii) a high number of mitochondria,
associated with increased metabolic activity; and (iv) the polar-
ized expression of membrane receptors and transporters, which
are responsible for the active passage of nutrients (Brightman and
Kadota, 1992; Petty and Lo, 2002). Consistently, the permeability
of plasma and ionic compounds in the cerebral endothelium is
highly restricted and regulated—a phenomenon evidenced by a
high trans-endothelial electric resistance (TEER; Petty and Lo,
2002; Abbott et al., 2006). Another component of the BBB, the
basal lamina, is classified according to the cell source. The basal
lamina of the endothelium is composed of three layers: one con-
tains laminin-4 and -5 derived from ECs, one contains laminin-1
and -2 derived from astrocytes, and the other contains collagen IV
derived from both cell types (Perlmutter and Chui, 1990).
The role of astrocytes in BBB function and integrity has been
well documented; however, their molecular mechanisms of action
remain unclear (Anderson et al., 2003; Giffard and Swanson,
2005; Thoren et al., 2005; Barreto et al., 2011). Astrocytes form
structures called “astrocyte end-feet” that communicate with
neurons, pericytes, and ECs. This cell population is very impor-
tant because it modulates synaptic transmission and processes of
neuronal plasticity (Ullian et al., 2001; Allen and Barres, 2005;
Kucukdereli et al., 2011). These cells also maintain homeostasis by
releasing sodium after action potentials, maintaining metabolic
homeostasis via insulin, glucose and lactate signaling, and releas-
ing hormones in response to various behaviors (Nedergaard et al.,
2003; Newman, 2003; Abbott et al., 2006). It has been suggested
that astrocytes contribute support to the BBB via the release
of factors including glial cell line-derived neurotrophic factor
(GDNF), angiopoietin-1, and angiotensin II (Lee et al., 2003; Hori
et al., 2004; Wosik et al., 2007).
Complementarily, pericytes and the basal lamina surround
ECs along the cerebral microvasculature. This cerebral microvas-
culature is enriched in pericytes, and the ratio of pericytes to
ECs correlates to the barrier capacity of the endothelium. In
addition, pericytes are actively involved in the maintenance of
vessel integrity, vasoregulation, and the regulation of BBB perme-
ability (Lindahl et al., 1997; Peppiatt et al., 2006; Armulik et al.,
2010). Finally, it has been observed that neuronal projections
are closely related with the cerebral endothelium (Hamel, 2006;
Drake and Iadecola, 2007; Weiss et al., 2009). These perivascular
neurons use perivascular astrocytes and pericytes to modulate
brain blood flow and vessel dynamics (Hamel, 2006; Wang and
Bordey, 2008; Sofroniew and Vinters, 2010). Recently, it has
been demonstrated that the close proximity of these different cell
types to neurons facilitates effective paracrine regulation, which is
critical for the normal function of the CNS; however, the impaired
paracrine regulation induces the development of neurological
diseases (Berzin et al., 2000; Zlokovic, 2005). The normal function
of the CNS requires the regulation of neurovascular coupling,
microvascular hemodynamics and permeability, matrix interac-
tions, neurotransmitter inactivation, neurotrophic support, and
processes of neurogenesis and angiogenesis (Boillée et al., 2006;
Deane and Zlokovic, 2007). It is currently accepted that the
BBB limits the entrance of blood components into the cerebral
parenchyma. Therefore, injury to any part of the neurovascular
unit could permit the extravasations of vascular inflammatory
cells and proteins to brain tissue (del Zoppo, 2006). Extravasation
of the BBB due to cerebral ischemia, trauma, neurodegenerative
processes, or vascular disorders allows these neurotoxic products
to compromise synaptic and neuronal function (Hawkins and
Davis, 2005; Zlokovic, 2005; Abbott et al., 2006). When the brain
blood flow is interrupted, brain functions halt within seconds,
and neuronal damage occurs after a few minutes (Girouard and
Iadecola, 2006). An appropriate vasculature-neuron ratio is crit-
ical for normal brain function. It has been estimated that nearly
every neuron in the brain has its own capillary (Zlokovic, 2005).
The total length of the capillaries in the human brain is approx-
imately 400 miles, and the surface area available for molecular
transport is approximately 20 m2 (Begley and Brightman, 2003).
The length of the brain capillaries is reduced in neurodegenerative
disorders, such as AD and cerebral ischemia (Bailey et al., 2004;
Wu et al., 2005). These vascular reductions diminish the transport
of energy substrates and nutrients across the BBB and reduce
the clearance of potentially neurotoxic substances during brain
injury.
BBB DYSFUNCTION IN CEREBRAL ISCHEMIA
In a variety of neurological diseases (e.g., AD, ischemia, Hunt-
ington’s disease, Parkinson’s disease, and ALS), BBB dysfunction
has been detected not only as a late event but also at early stages
of disease progression. There are two types of BBB dysfunction
involving increased permeability: passive diffusion with edema
formation and massive cellular infiltration across the BBB (Weiss
et al., 2009). Acute obstruction of brain blood vessels due to
coagulation during cerebral ischemia involves a complex series of
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cellular and molecular events in the brain parenchyma (del Zoppo
and Mabuchi, 2003). The sequence of events from ischemia to
reperfusion begins with perivascular inflammation and increased
BBB permeability, which greatly contribute to brain damage,
thus supporting the notion that cerebral ischemia is primarily
a vascular disorder (Benchenane et al., 2004). The release of
oxidants, proteolytic enzymes, and proinflammatory cytokines
alters BBB permeability, leading to brain edema (Dirnagl et al.,
1999). In addition, metalloproteinases (MMPs) released by acti-
vated leukocytes affect NVU integrity, degrading the basal lamina
and the proteins involved in cell-cell adhesion (Hamann et al.,
1995; Rosenberg et al., 1998; Asahi et al., 2001). MMP-9 is
particularly critical during this process, as previous studies have
demonstrated that BBB integrity is maintained after cerebral
ischemia in MMP-9-deficient mice (Asahi et al., 2001; Montaner
et al., 2001). However, increased trans-endothelial migration of
leukocytes is characteristic during cerebral ischemia (Lindsberg
et al., 1996; Planas et al., 2006). Following ischemia, circulating
leukocytes release inflammatory cytokines and activate various
cell types within the NVU. For example, the increased expression
of intercellular adhesion molecule-1 (ICAM-1) by ECs facilitates
the trans-endothelial migration of leukocytes (Lindsberg et al.,
1996). Furthermore, it has been demonstrated that treatment
with anti-ICAM-1 antibodies reduces infarct size in rat models of
cerebral ischemia (Zhang et al., 1995). Another process of BBB
dysfunction that increases damage during cerebral ischemia is
the secretion of TGFβ by astrocytes, which diminishes endothe-
lial capillarity, fibrinolytic enzyme expression, and basal lam-
ina proteolysis. Additionally, BBB disruption coincides with the
induction of aquaporin 4 (AQP4) expression and the presence of
reactive astrocytes in the perivascular glial cells (Tran et al., 1999;
Lo et al., 2003; Tomás-Camardiel et al., 2005; Vakili et al., 2005).
Several chemical agents circulating in the plasma or secreted
from cells associated with the BBB are capable of increasing
brain endothelial permeability and impairing its transport and
metabolic functions (Laflamme et al., 1999; Abbott, 2000; Webb
and Muir, 2000). These agents include histamine, serotonin,
glutamate, purine nucleotides (ATP, ADP, and AMP), adenosine,
platelet-activating factor, phospholipase A2, arachidonic acid,
prostaglandins, leukotrienes, tumor necrosis factor-α (TNFα),
free radicals and nitric oxide (Laflamme et al., 1999; Abbott, 2000;
Webb and Muir, 2000; Tan et al., 2002; Stolp and Dziegielewska,
2009). Bradykinin, which is produced during inflammation in
stroke, acts on endothelial and astroglial bradykinin B2 receptors,
leading to an increase in intracellular Ca2+ concentrations. In
astrocytes, this event can trigger the production of interleukin
(IL)-6 and IL-1 via nuclear factor-κB (NF-κB) activation (Deli
et al., 1995; Schwaninger et al., 1999; Didier et al., 2003; Perry
et al., 2003). The role of the microglia in pathological NVU activ-
ity has been proposed to induce damage to the endothelium and
the basal lamina via receptors for nucleotides, such as ATP, and
opening new routes of communication between ECs, pericytes,
astrocytes and microglia is important for BBB repair (Deitmer
et al., 2001; Andersson et al., 2005). However, recent studies
have demonstrated that enhancing the activation of microglia
promotes tissue repair and remodeling after stroke by decreasing
the levels of the inflammatory markers IL-1β and TNF-α and
increasing IL-1ra, IL-10, and arginase 1 expression (Gelosa et al.,
2014; Shin et al., 2014).
Apparently, the NVU performs a coordinated response after
an ischemic insult to maintain and re-establish blood flow over
time, thus reducing damage to tissue and neurons. Aside from
the notion that occlusion affects vulnerable regions, this hypoth-
esis supports the need to understand the interactions between
each component of the NVU in the pathophysiology of cerebral
ischemia and recovery following therapy (Nedergaard et al., 2003;
Zonta et al., 2003; Iadecola, 2004; Abbott et al., 2006; Koehler
et al., 2009). The strategy of protection of neuronal function in
humans was not successful in preventing damage progression,
indicating that there is a mechanism that is inherent to NVU
coupling. Moreover, there is a relapse of the NVU function that
leads to vascular dementia (del Zoppo, 2010), despite the intrinsic
recovery of the tissue and of cognitive abilities. Although the use
of neuroprotective agents has generally failed as a potential thera-
peutic strategy following cerebral ischemia in translational trials,
thrombolysis using tissue plasminogen activator (tPA) continues
to be the gold standard intervention during the acute phase after
stroke (van der Worp and van Gijn, 2007). Importantly, neuro-
protective agents should be administered early by the emergency
medical system (EMS) to improve neuroprotection in the long
term (Saver, 2013), which also helps to prevent the impairment
of the integrity of the NVU and avoid cerebral dysfunction.
Therefore, in an attempt to understand the interdependency of
the components of the NVU, its integrity and how to protect it,
we will focus on certain implicated tissue and cellular effectors.
INTERCELLULAR JUNCTIONS IN THE BBB
ECs are primarily connected via junction complexes, which con-
sist of TJs and adherens junctions (AJ; Hawkins and Davis,
2005). Although gap junctions (GJ) have also been found in the
BBB, their role remains unclear (Nagasawa et al., 2006). TJs are
primarily the junctions that confer a low paracellular permeability
and TEER to the BBB (Bazzoni et al., 2005). TJ physiology is
complex. TJ proteins and their adaptor molecules, which are
connected to the cytoskeleton, are often affected during acute and
chronic brain disease (Wolburg and Lippoldt, 2002). Occludin
was the first integral protein to be identified in TJs of ECs
involved in the BBB. It has been demonstrated that the N-terminal
domain of occludin plays an important role in TJ assembly and
the maintenance of barrier function (Bamforth et al., 1999). In
contrast, deletion of the occludin gene in mice results in a complex
phenotype, including a delay in postnatal growth, due to the
efficient permeability of the barrier caused by a diminished TEER
and an increased paracellular flow of macromolecules (Bamforth
et al., 1999; Saitou et al., 2000). Occludin is also vulnerable
to degradation by MMPs (Rosenberg and Yang, 2007). Damage
caused by reperfusion in ischemic models in rodents leads to
a biphasic opening of the BBB—a process directed by MMP-2
activation during the acute phase that occurs for several hours
after reperfusion (Zlokovic, 2006). This initial transient opening
is followed by more intense damage to blood vessels from 24 to
48 h after reperfusion, which is associated with the expression of
MMP-9 and MMP-3 (Suzuki et al., 2007). MMPs can also degrade
basal lamina components, such as fibronectin, contributing to
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BBB rupture (Cheng et al., 2006; Zlokovic, 2006). Claudins are
a family consisting of more than 20 members that generate TJ
chains via hemophilic claudin-claudin interactions. Claudin −5,
−3, and −12 are located on the BBB, whereas the localization of
claudin-1 is controversial. With regard to the function of claudins
at the BBB, it has been found that each claudin isoform regulates
the diffusion of a group of molecules of a particular size (Wolburg
and Lippoldt, 2002; Lee et al., 2003; Nitta et al., 2003). Although
claudin-5 protein expression is low in brain ECs, during BBB
rupture, this protein is a target of MMP-2- and MMP-9-mediated
degradation after ischemia and, together with occludin, is found
near astrocytes (Yang et al., 2006). Integral TJ membrane proteins
are attached to the cytoskeleton by cytoplasmic multi-domain
scaffolding proteins, such as ZO-1, ZO-2, and ZO-3 (Hawkins
and Davis, 2005; Hawkins et al., 2007), and these proteins are also
targets of MMP-mediated degradation during CNS injury. Essen-
tially, BBB opening during cerebral ischemia is clearly induced by
the MMP-mediated degradation of TJs; however, it has recently
been demonstrated that MMPs also participate in the regulation
of neurogenesis and angiogenesis during the recovery phase after
injury (Fujioka et al., 2012). This beneficial characteristic of MMP
activity was demonstrated in a late event ischemia model (7–14
days), in which treatment with MMP inhibitors 7 days after
stroke suppressed neurovascular remodeling, increased injury,
and impaired cognitive function. It has been suggested that these
effects are primarily due to a decrease in VEGF availability. There-
fore, clarification regarding the therapeutic potential of MMP
inhibition for different brain pathologies has been recommended
(Zhao et al., 2006). Alternatively, AJs typically crosstalk with TJs.
AJs are a type of cell-cell adhesive contact found in many tissues,
and AJs use a cadherin dimer as the primary mediator of cell-
cell adhesion. Endothelial permeability is regulated in part by
the dynamic opening and closing of AJs (Bazzoni and Dejana,
2004). In ECs, AJs primarily consist of vascular endothelial cad-
herin (VE-cadherin), an endothelium-specific member of the
cadherin that binds to p120 catenin, β-catenin, and plakoglobin
via its intracytoplasmic domain (Dejana et al., 2008). Multiple
endogenous pathways that increase vascular permeability affect
the function and organization of VE-cadherin (Bazzoni and
Dejana, 2004). Loss of VE-cadherin is accompanied by an increase
in vascular permeability and leukocyte diapedesis, and internal-
ization and cleavage of VE-cadherin can disassemble AJs at cell-
cell junctions (Lampugnani and Dejana, 2007). Changes in AJ
proteins expression contribute to increased BBB permeability and
leukocyte infiltration into the CNS (Allport et al., 1997; Johnson-
Léger et al., 2000). Several mechanisms by which VE-cadherin
regulates endothelial function have been proposed, such as the
direct activation of signaling molecules to maintain survival and
the organization of the actin cytoskeleton (e.g., PI3 kinase and
Rac), the regulation of gene transcription co-factors (e.g., p120
catenin, β-catenin), the formation of complexes with growth fac-
tor receptors, including the vascular endothelium growth factor
receptor-2 (VEGFR-2), and the modulation of VEGFR-2 signaling
(Bazzoni and Dejana, 2004). The roles of AJs in the functional
and morphological changes in the BBB during cerebral ischemia
have not been addressed in depth. The direct activation of oxygen-
sensitive transcription factors, such as HIF-1 and reactive oxygen
species (ROS), can directly activate transcription factors, such as
NF-κB, which alter AJ formation. The increase in intracellular
calcium levels that characterizes cerebral ischemia can lead to
the transduction of signals that regulate AJ and TJ transcription,
consequently inducing changes in BBB function (Brown and
Davis, 2002). Based on these studies, it is necessary to develop
strategies to maintain NVU structure and function after cerebral
ischemia by focusing on obtaining a deeper understanding of the
cell-cell junctions present in the BBB.
Rho GTPases IN ECs REGULATE BBB INTEGRITY
The importance of the cytoskeleton in BBB integrity and estab-
lishment was initially demonstrated in mice deficient in the
actin-binding protein dystrophin (Nico et al., 2003). These mice
displayed increased vascular permeability, as the ECs and astro-
cytes formed a disorganized actin cytoskeleton, as well as altered
subcellular localization of junction proteins in the endothelium
and aquaporin-4 at astrocyte end-feet (Nico et al., 2003). These
findings demonstrated that the arrangement of actin filaments
and their junctions to TJs and/or AJs are critical for normal
BBB function. The actin cytoskeleton plays an essential role in
maintaining the barrier function of the endothelium because
it determines cell shape, facilitates cell-matrix adhesion, and
participates in the regulation of junction complexes (Dejana,
2004). It has been determined that the dynamics and structure
of the actin filaments are primarily regulated by Rho GTPase
proteins (Ridley, 2001; Lampugnani et al., 2002; Aspenstrom
et al., 2007; Aghajanian et al., 2008; Vandenbroucke et al., 2008).
The Rho family of GTPases belongs to the Ras superfamily,
which consists of low molecular weight, monomeric G-proteins.
Rho GTPases have recently been classified into six subfamilies:
RhoA, Rac1, Cdc42, Rnd, RhoBTb, and Rho/Miro (Ridley, 2001;
Lampugnani et al., 2002; Aspenstrom et al., 2007; Aghajanian
et al., 2008; Vandenbroucke et al., 2008). Specifically, RhoA
induces the formation of actin stress fibers and focal adhe-
sions, Rac1 stimulates lamellipodial protrusions (membrane ruf-
fling), and Cdc42 promotes the formation of filopodia (actin
microfilaments) (Ridley and Hall, 1992; Nobes and Hall, 1995).
In in vivo experiments, multiple vasoactive agents improved
endothelial barrier integrity by forming a dense F-actin band
via changes in the activities of various Rho GTPases (Garcia
et al., 2001; Temmesfeld-Wollbrück et al., 2007; Tauseef et al.,
2008). Initially, RhoA activation was found to be important
because RhoA regulates cell contraction and endothelial hyper-
permeability (Sun et al., 2006). In subsequent years, attention
was directed toward the involvement of Rac and Cdc42 in the
assembly and stability of inter-endothelial junctions. Further-
more, a recently discovered role of RhoA and its downstream
effector ROCK in barrier maintenance was identified (Broman
et al., 2007; Fu and Birukov, 2009). An important role of Rho
GTPases in BBB regulation is that they act as mediators of
barrier damage or protection (Beckers et al., 2010). Although
Rac1 primarily modulates the stability of cell-cell junctions,
its activity on NADPH oxidase-mediated ROS generation par-
ticipates in BBB damage after injury (Broman et al., 2007;
Monaghan-Benson and Burridge, 2009). Likewise, RhoA plays
a dual role in barrier regulation. For example, RhoA exerts a
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protective function under basal conditions, but it is involved
in BBB dysfunction after EC activation by thrombin (Broman
et al., 2007; van Nieuw Amerongen et al., 2008). In particular,
RhoA activity is involved in the progression of neuronal death
during cerebral ischemia (Semenova et al., 2007). In our study,
we found that there is a differential regulation of Rho GTPases
due to global and transient focal cerebral ischemia. We demon-
strated that Rho/ROCK inhibition is involved in neuroprotection
(Castro-Alvarez et al., 2011). Additionally, we found that
treatment with statins—a class of drugs used to reduce
cholesterol—diminished RhoA activity, which is associated with
decreased levels of neurodegeneration markers and neuronal
death (Céspedes-Rubio et al., 2010). Some of the mechanisms
associated with the neuroprotective role of statins include the
downregulation of RhoA activity and the subsequent induc-
tion of endothelial nitric oxide synthase (eNOS) activity (Wang
et al., 2008). Finally, we discovered that Rac1 activity is involved
in long-term recovery from neurodegeneration after cerebral
ischemia (Gutiérrez-Vargas et al., 2010). Because the function
of Rho GTPase is essential for NVU regulation (including the
endothelium, neurons, and adhesion proteins), the challenge of
maintaining BBB integrity lies in determining the complex reg-
ulation of Rho GTPases, which will provide indications for new
therapeutic strategies for ischemic injury.
CDK5, A TARGET FOR CEREBRAL ISCHEMIA
CDK5 is a serine-threonine kinase that participates in neuronal
development and function and is involved in the regulation of
various processes, such as neuritogenesis, synapse formation, and
synaptic transmission (López-Tobón et al., 2011; Su and Tsai,
2011). CDK5 also plays an important role in the regulation of
apoptosis during development, which is essential for the pruning
and fine-tuning of neural connections, and is involved in cog-
nitive functions, such as memory and learning. In addition, the
deregulation of CDK5 activity is associated with neuronal death
in neurodegenerative diseases (Dhavan and Tsai, 2001; Lai and Ip,
2009). CDK5 activity is primarily regulated by p35 and p39, and
the phosphorylation of CDK5 at Ser159 and Tyr15 increases its
activity (Zukerberg et al., 2000; Grant et al., 2001). Cleavage of
p35 by calpains results in the formation of a CDK5/p25 complex,
leading to considerable sustained abnormal CDK5 kinase activity
(Cheung et al., 2006). Morphological characteristics, such as the
density and morphology of dendritic filaments, and biochemical
characteristics, such as the composition of postsynaptic density
scaffold proteins and the number of neurotransmitter receptors,
determines the properties of synaptic activity. Many synaptic pro-
teins isolated from adult brain synaptosomes are putative CDK5
substrates, rendering CDK5 a synapse regulator (Collins et al.,
2005). CDK5 is involved in cognitive deterioration in cerebral
ischemia and neurodegeneration (Slevin and Krupinski, 2009;
Menn et al., 2010). In addition to the many studies showing that
CDK5 hyperactivation is involved in tau hyperphosphorylation
and the subsequent development of dementia in neurodegen-
erative diseases (Ko et al., 2001; Camins et al., 2006), multiple
pieces of evidence have implicated CDK5 in the progression of
cerebral ischemia pathology. Increased expression levels of CDK5
and its activator p35 are detected in peri-infarct neurons following
middle cerebral artery occlusion (MCAO; Green et al., 1997;
Mitsios et al., 2007). In cerebral ischemia models, pharmaco-
logical inhibition of CDK5 significantly reduces the infarct size
after 24 h of reperfusion (Weishaupt et al., 2003). AD and other
tauopathies, such as cerebral ischemia, are characterized by the
hyperphosphorylation of the protein tau (Grundke-Iqbal et al.,
1986; Avila et al., 2004). Particularly, CDK5, along with its respec-
tive activators, phosphorylates tau at epitopes that are associated
with neurodegenerative processes. Deregulated CDK5 activity is
produced by the membrane-released CDK5/p25 complex, leading
p25 to induce an atypical and sustained activation of CDK5,
which leads to the hyperphosphorylation of its substrates that
are associated with disease progression. Overexpression of p25 in
neuronal cultures produces cytoskeletal damage, tau hyperphos-
phorylation, and apoptosis (Patrick et al., 1999; Wen et al., 2008).
Because CDK5 inhibition protects against neuronal death and
reduces tau hyperphosphorylation (Lopes et al., 2007; Piedrahita
et al., 2010) and because the atypical activation of CDK5 is a
fundamental component of the progression of the neurofibrillary
pathology, CDK5 inhibition has been proposed as a potential
therapeutic strategy for neurological diseases. During glutamate-
mediated excitotoxicity, the excessive influx of Ca2+ can acti-
vate the Ca2+-dependent protease calpain. Calpain is involved
in the degradation of numerous enzymes and cytoskeletal com-
ponents, thus linking its activity to a variety of intracellular
events involved in CNS alterations associated with excitotoxicity,
such as hypoxia, ischemia, epilepsy, and AD (Ray and Banik,
2003). Recently, it has been shown that CDK5 phosphorylates
the NMDA receptor subunit NR2A, causing neuronal death in
the CA1 area of the hippocampus in a transient global cerebral
ischemia model. This finding suggests a possible therapeutic
approach in which CDK5 inhibition targets glutamate receptors
(Wang et al., 2003). Alternatively, previous studies have reported
the involvement of CDK5 in the progression of neurovascular
pathology. Importantly, patients suffering from cerebral ischemia
display strong up-regulation of CDK5, p35, and p25 in peri-
infarct blood vessels; additionally, human brain microvascular
endothelial cells (HBMECs) subjected to glucose deprivation dis-
play hyperactivation of CDK5, suggesting a crucial role of CDK5
in the microvasculature in response to cerebral ischemia (Slevin
and Krupinski, 2009).
CDK5 IN THE ENDOTHELIUM AND ASTROCYTES
Early investigation of CDK5 function in ECs included stud-
ies that demonstrated decreased CDK5 expression when EC
proliferation was inhibited by angiotensin. In a 2008 study,
Liu and colleagues demonstrated that mitogenic growth factors
activated the PI3K/Akt pathway, followed by CDK5-mediated
phosphorylation of PIKE-A (a factor that hyperactivates phos-
phatidylinositol 3-kinase (PI3K)) in glioblastoma cells. These
findings suggest that CDK5 may play a significant role in the
regulation of EC proliferation (Sharma et al., 2004; Liu et al.,
2008). One recently emergent function of CDK5 is that it acts
as a regulator of the endothelium during angiogenesis and EC
migration, thus contributing to various pathological conditions.
Therefore, CDK5 has been proposed as a novel target for anti-
angiogenic therapy (Liebl et al., 2010). In in vivo and in vitro
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models, such as neovascularization of the mouse cornea and
endothelial tube formation, pharmacological inhibition of CDK5
resulted in reduced endothelial cell motility and angiogenesis,
suggesting an effect independent of its previously characterized
functions in neurons and a specific role of CDK5 signaling in
the endothelium (Liebl et al., 2011). In contrast to its activity
in neurons, the reduction in endothelial cell motility induced
by CDK5 inhibition was not caused by altering the function
of focal adhesions or microtubules, but rather by a reduction
in lamellipodia formation (Liebl et al., 2010). CDK5 inhibition
diminished Rac1 activity, leading to actin cytoskeleton disorgani-
zation, which suggests that CDK5 exerts its effects on endothelial
cell migration via Rac1. Taken together, these findings indicate
CDK5 as a pharmacologically accessible target for anti-angiogenic
therapy and provide a basis for a new therapeutic strategy for
cerebral ischemia.
One event that follows cerebral ischemia is the formation of
new blood vessels. Recently, it has been shown that targeting
p35/CDK5 using a specific peptide inhibitor (CIP) in a hypoxia
model preserves cell motility and temporal control of actin
cytoskeletal dynamics and protects and promotes angiogenesis
(Bosutti et al., 2013). Although new vessels are the source of
trophic factors during the early stages of brain parenchyma
recovery, sustained angiogenesis becomes a physical barrier
to neural circuit formation and connection refinement (Liebl
et al., 2010). In addition, a previous study proposed roscovitine
(an inhibitor of CDK5 and other CDKs) administration for
the prevention of endothelial activation and the leukocyte-EC
interaction during parenchymal leukocyte infiltration (Berberich
et al., 2011). These studies could expand the use of CDK5
inhibition because of its promising anti-inflammatory effects, in
addition to maintaining BBB integrity. Finally, CDK5 regulates
eNOS enzyme activity. eNOS is an essential enzyme responsible
for the production of endothelium-derived NO, which is a key
molecule that performs multiple functions, including vascular
homeostasis, angiogenesis, and cell cycle regulation (van Haperen
et al., 2002; Desjardins and Balligand, 2006; Bonnin et al.,
2012). CDK5 phosphorylates eNOS at Ser113 and Ser116, thus
regulating nitric oxide (NO) levels (van Haperen et al., 2002;
Desjardins and Balligand, 2006; Cho et al., 2010; Lee et al.,
2010). eNOS deregulation contributes to the pathophysiology
of multiple diseases, such as atherosclerosis, hypertension, and
cancer (Desjardins and Balligand, 2006). It is well known that
eNOS phosphorylation modulates its activity (Harris et al.,
2001; Mount et al., 2007). Phosphorylation of eNOS by CDK5
is associated with decreased NO production (Cho et al., 2010).
This mechanism may explain how NO is maintained at minimal
levels at a basal state in ECs and how CDK5 contributes to the
pathogenesis of diseases associated with reduced NO release from
ECs. However, further studies are required to clarify these issues.
A few studies have shown that CDK5 and p35 are expressed
in astrocytes in the adult brain. Additionally, it has been demon-
strated that the activity of CDK5 and its activator p35 participate
in the process of scratch-wound migration in a wound-healing
model via the regulation of microtubules in primary astrocyte
cultures (He et al., 2007). Likewise, increased CDK5 activity
is involved in tau hyperphosphorylation, oxidative stress and
the degeneration of astrocytes in a murine senescence model
(García-Matas et al., 2008). Primarily, in GFAP/tau transgenic
mice, a unique astrocytic tau pathology model, astrocytes have
been identified as playing a role in the neurodegenerative pathol-
ogy that is associated with CDK5 hyperphosphorylation (Forman
et al., 2005). To date, there have been few findings involving CDK5
in astrocytic and endothelial function. Therefore, further studies
of the possible role that this kinase might play in these cell types, as
well as in other brain neurovascular cell types, namely microglia
and oligodendrocytes, should be addressed.
REGULATION OF CELL ADHESION BY p120 CATENIN IN NVUs
The neural component of the NVU is partially regulated
by a group of cell adhesion molecules. Specifically, the
catenin/cadherin system interacts with and regulates the architec-
ture of the actin cytoskeleton (Salinas and Price, 2005). Neuronal
morphology and plasticity require a dynamic actin cytoskeleton
(Dillon and Goda, 2005). p120 catenin, in particular, regulates
synapse development and morphology via Rho GTPases, which
control actin cytoskeleton dynamics (Elia et al., 2006). Simultane-
ously, CDK5, via the phosphorylation of δ-catenin (a p120 catenin
family member), participates in the processes of synaptic trans-
mission (Poore et al., 2010). Therefore, with respect to neurons,
it is possible to suggest an association between CDK5 activity
and modulation of p120 catenin that facilitates neural plasticity
processes. However, the possible relationship between the
functions of CDK5 and p120 catenin has not been explored in the
endothelium. p120 catenin plays an essential role in the regulation
of cadherins, and increased endothelial adhesion mediated by
this protein (Anastasiadis and Reynolds, 2000) has been proposed
to regulate the actin cytoskeleton via Rho GTPases (Anastasiadis,
2007). In addition, evidence indicates that the interaction between
p120 catenin and cadherins promotes AJ stability (Xiao et al.,
2003; Kowalczyk and Reynolds, 2004; Oas et al., 2010). Previous
studies have shown that RNAi-mediated silencing of p120
catenin results in the loss of cadherin expression and subsequent
destabilization of AJs in the microvasculature (Davis et al., 2003;
Xiao et al., 2003). The binding of p120 catenin to VE-cadherin
prevents clathrin-dependent endocytosis, as the cadherin-catenin
system remains intact in the membrane. In addition, cytoplasmic
p120 catenin that is dissociated from VE-cadherin acts as a
regulator of Rho GTPase activity, which is involved in cell
migration and morphological changes via pseudopodia and stress
fiber formation (Anastasiadis and Reynolds, 2001). A recent study
has suggested the fine regulation of endothelial cell adhesion by
AJs, in which p120 catenin plays a critical role in regulating the
distribution of cadherins in lipid rafts of endothelial membranes,
which has consequences on the stabilization of cadherins and cell
signaling (Gentil-Dit-Maurin et al., 2010). The finding that the
deletion of p120 catenin from skin increases inflammation via
RhoA-NF-κB has important implications for diseases in humans
(Perez-Moreno et al., 2006). The NF-κB pathway is involved
in cell survival, inflammation, and often tumor progression
(Cozzolino et al., 2003; Perez-Moreno et al., 2006). Finally, these
experimental findings, together with our results (Céspedes-Rubio
et al., 2010), suggest p120 catenin as a critical biomarker of the
recovery of the NVU after cerebral ischemia.
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NEURON-TO-ASTROCYTE CONTROL OF NEUROVASCULAR
COUPLING
Originally, astrocytes were considered supporting cells that play
no role in neurotransmission in the CNS. However, studies have
shown that astrocytes display a large conductance of potassium
ions (K+) during an action potential in presynaptic neurons.
K+ passes into the blood vessel via gap junctions for removal
after a long period of neuronal activity (Massey et al., 2004;
Wallraff et al., 2004; Jabs et al., 2005). Previous studies have shown
that this passive role of astrocytes in the synapse changes over
time, as hippocampal astrocytes in culture respond to chemical
transmitters, such as glutamate (neurotransmitter), generating a
Ca2+ wave that propagates to surrounding astrocytes (Leybaert
et al., 1998; Cotrina et al., 2000). Initially, glutamate was shown
as a propagator of waves in astrocytes. However, other investiga-
tions have suggested that norepinephrine, GABA, acetylcholine,
histamine and adenosine induce Ca2+ elevation in glial cells
derived from ex vivo preparations of adult brain slices (Duffy and
Macvicar, 1995; Porter and McCarthy, 1995; Kulik et al., 1999;
Shelton and McCarthy, 2000; Bowser and Khakh, 2004). Some
of the signals in the neuron-to-astrocyte direction are mediated
by metabotropic receptors, such as mGluR1/5. The activation of
these receptors by glutamate released at synapses induces phos-
pholipase C (PLC) activation, IP3 formation and, subsequently,
IP3R activation, which facilitates the release of calcium into the
cytosol from the ER (Kawabata et al., 1996; Wang et al., 2000).
Calcium waves transmit signals between astrocytes, as this Ca2+
signal propagates to neighboring astrocytes via the diffusion or
release of IP3 and the subsequent activation of purinergic P2Y
receptors in neighboring astrocytes (Venance et al., 1997; Guthrie
et al., 1999). Finally, the discovery of gliotransmitters (including
glutamate, D-serine and ATP), chemicals released from astrocytes
that affect the transmission between pre- and post-synaptic neu-
rons, led to the concept of the tripartite synapse, which states that
the activation of astrocytes associated with increased intracellular
Ca2+ results in the direct activation of the neighboring neurons
(Fiacco and Mccarthy, 2004; Gordon et al., 2005; Panatier et al.,
2006). Neuronal activation by astrocytes is thought to occur via
NMDA receptors that are primarily composed of NR2B subunits
and is directly involved in neuronal plasticity (Fellin et al., 2004;
Massey et al., 2004). Recently, studies using conditional knockout
of CDK5 in the adult mouse brain showed improved performance
in spatial learning tasks and enhanced hippocampal long-term
potentiation via NR2B-mediated excitatory postsynaptic currents
(Hawasli et al., 2007; Plattner et al., 2014). This finding, in asso-
ciation with the finding that gene silencing of CDK5 decreased
neuropathologic characteristics of neurodegeneration, such as
neurofibrillary tangles (Piedrahita et al., 2010), may suggest that
the use of RNAi-mediated suppression of CDK5 expression in
astrocytes promotes the tripartite synapse and recovery from
cognitive impartment after stroke.
Concomitant with the function of astrocytes in the regulation
of synapses, these cells directly regulate cerebral circulation, as
they modulate the level of neural activity and, consequently,
that of local microcirculation (Roy and Sherrington, 1890;
Friedland and Iadecola, 1991; Pellerin and Magistretti, 1994).
Sites of synaptic transmission that display high-energy demand
during neuronal activity also display increased blood flow, which
results in the rapid expansion of arterioles and capillaries (Lou
et al., 1987; Magistretti et al., 1999; Kasischke et al., 2004).
The propagation of calcium waves in astrocytes via glutamate
receptors has been proposed to regulate blood flow during
neuronal activity because these cells secrete vasoactive substances,
such as NO, the product of iNOS, factors derived from the activity
of cyclooxygenase (COX) and epoxygenase, such as prostaglandin
E2 (PGE2), epoxyeicosatrienoic acid, and ATP, towards neurons,
astrocytes, and ECs (Oomagari et al., 1991; Alkayed et al., 1997;
Wiencken and Casagrande, 1999; Arcuino et al., 2002). Neuron-
to-astrocyte activation via the activity of Ca2+-sensitive phospho-
lipase A2 and the accumulation of arachidonic acid can induce
vasodilation or vasoconstriction through its metabolic pathways.
COX-2-dependent accumulation of PGE2 leads to vasodilation,
whereas diffusion of arachidonic acid into smooth muscle leads
to the accumulation of 20-HETE, causing vasoconstriction (Bezzi
et al., 1998; Harder et al., 2002). This phenomenon reflects
neurovascular coupling and has been defined as vasomotion
(Filosa et al., 2004), in which the microvascular hemodynamics
are regulated by the energy and oxygen demand to an
undersupplied organ, i.e., low O2 conditions. This event triggers
astrocytes to induce vasodilation in the endothelium to promote
the entry of nutrients and O2 (Ward et al., 2000; Brown et al.,
2002; Lovick et al., 2005). This bifunctional role of astrocytes
in neurovascular coupling and synaptic transmission implicates
these cells as important targets for functional recovery of the
NVU, including neurons, glia, and ECs, after cerebral ischemia.
ASTROCYTES AND MODULATION OF EXCITOTOXICITY
Astrocytes, the most abundant CNS cell population, are a type
of glial cell that performs diverse functions, such as providing
trophic and metabolic support to neurons (Rouach et al., 2008;
Dienel, 2013), participating in differentiation, neuronal polarity,
and synaptogenesis during development (new synapse formation)
(Allen, 2013) and facilitating synaptic processes (Ullian et al.,
2001; Allen and Barres, 2005; Kucukdereli et al., 2011). These
functions render astrocytes as essential for the maintenance of
brain homeostasis (Parpura and Verkhratsky, 2012) and neuronal
survival (Sofroniew, 2005). In recent years, it has been determined
that astrocytes participate in cerebral recovery following cell
damage, particularly following damage caused by cerebrovascular
diseases (CVD) or neurodegenerative disease. In such injuries, a
common process that induces cell death is glutamate-mediated
excitotoxicity (Matute et al., 2007; Guimarães et al., 2010).
Astrocytes influence neuronal survival following brain injury
via glutamate uptake, free radical removal, water transport, and
cytokine and NO production. Glutamate uptake is a process
in which astrocytes absorb extracellular glutamate via highly
expressed glutamate transporters to maintain transmitter home-
ostasis (Rothstein et al., 1996; Bush et al., 1999; Swanson et al.,
2004). Glutamate transporters play a major role in maintaining
brain homeostasis, and the astrocytic excitatory amino acid
transporters (EAATs) EAAT1 and EAAT2 are functionally
dominant. Astrocytic EAATs play important roles in various neu-
ropathologies in which astrocytes undergo cytoskeletal changes
(Zagami et al., 2009; Lau et al., 2010). In addition, after brain
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damage, astrocytes assist in the recovery of plasticity processes,
such as long-term potentiation (LTP), via the expression of
trophic and molecular factors on their surface that favor neuronal
growth or regeneration and new synapse formation (Matute et al.,
2007; Adelson et al., 2012; Lin et al., 2014; Wang et al., 2014).
Astrocytes respond to brain injury via a process called reac-
tive astrogliosis (Sofroniew and Vinters, 2010), in which astro-
cytes change their morphology and metabolism, converting from
a fibrillary or protoplasmic morphology to a hypertrophic or
swollen structure, which is primarily characterized by the ele-
vated expression of intermediate filaments and proteins related
to metabolic acidity. Over time, this astroglial hyperreactivity
process creates a scar that impedes NVU repair; thus, reactive
astrogliosis is considered an important marker of structural
injury (Di Giovanni et al., 2005; Buffo et al., 2010). In an
NVU homeostasis context, astrocytes are star-shaped (fibrillar)
and have many extensions irradiating from the soma towards
neighboring cells, which facilitate their performance of func-
tions involving neuronal migration, support, and maintenance
(Zonta et al., 2003; Sofroniew, 2005; Wang and Bordey, 2008;
Buffo et al., 2010). In contrast, in a pathological context, such
as ischemia, astrocytes near the injured area change, acquiring
a fibrous appearance and thick extensions (Xiong et al., 2011;
Barreto et al., 2012). The morphological changes in astrocytes
are primarily mediated by actin cytoskeleton remodeling (Hall,
1998; Hall and Nobes, 2000). Furthermore, this actin cytoskele-
ton repair system is mediated by Rho GTPases (Bustelo et al.,
2007). Recently, it has been demonstrated that RhoA/ROCK
activity induces a protoplasmic morphology in primary astro-
cyte cultures, as opposed to the function of Rac1, which favors
stellation or the generation of new protrusions in astrocytes
(Racchetti et al., 2012). In addition, ROCK plays a major role
in determining the cell surface expression of EAAT1/2, providing
evidence for an association between transporter function and
astrocytic glutamate uptake. ROCK inhibitors elevate glutamate
transporter function; this activity profile may contribute to their
beneficial effects on neuropathologies (Lau et al., 2011). In con-
trast, the role of Rac1 in astrocytes is associated with not only
their stellar morphology but also their survival. A study con-
ducted using human glioma cells demonstrated that suppress-
ing Rac1 activity induces apoptosis, in contrast to the results
using primary astrocytes from humans (Senger et al., 2002).
This evidence suggests that Rac1 regulates certain pro-survival
pathways that are abnormally activated in this type of tumor.
In addition, Rac activation by PI3K has been associated with
PI3K/Akt activation, which promotes cell survival (Dey et al.,
2008; Linseman and Loucks, 2008; Read and Gorman, 2009).
Similarly, the Rac1 activator Tiam performs an important func-
tion in astrocyte polarization and migration during development
or cell repair by affecting the organization of the microfilament
and microtubule networks (Ellenbroek et al., 2012). Alternatively,
cellular senescence is a tumor-suppressive process that is char-
acterized by irreversible cell cycle exit, a unique pathway that is
upregulated by CDK5 activation. The increased CDK5 activity
further reduces GTPase Rac1 activity and Pak activation. The
repression of GTPase Rac1 activity by CDK5 that is required
for the expression of the senescent phenotype may suggest
CDK5-mediated Rac1 suppression as a marker of cell death
(Alexander et al., 2004).
Finally, filamentous tau aggregates have been detected in astro-
cytes in human disease and in animal models, and this process
disturbs glutamate uptake and other astrocyte functions, leading
to focal neurodegeneration (Forman et al., 2005; Dabir et al.,
2006). GSK3β and Cdk5 kinase activity, which regulate tau phos-
phorylation, are also increased in astrocytes of the senescence-
accelerated mice prone (SAMP8) model. Inhibition of GSK3β
using lithium or inhibition of CDK5 using roscovitine has been
shown to reduce tau phosphorylation at Ser396. Moreover, a
reduced mitochondrial membrane potential in SAMP8 mouse
astrocytes suppresses glutamate uptake in astrocytes, which is a
critical neuroprotective mechanism (García-Matas et al., 2008).
A POSSIBLE THERAPEUTIC STRATEGY FOR NVU
MODULATION
Our research group found that CDK5 gene silencing reduces
histopathological markers associated with cognitive disorders
(PHF-1), preventing the neurodegeneration and neuronal loss
in AD mice (Piedrahita et al., 2010). We also found that Rho
GTPases (Rac and RhoA) are involved in both damage and sur-
vival signaling mechanisms. For example, our recent studies show
that inhibition of RhoA/ROCK using Y27632 blocks the cascade
of neurodegeneration triggered by cerebral infarction, prevents
the deregulation of kinases involved in neuronal cytoskeletal
remodeling, such as CDK5, favors synaptic connectivity and pro-
tects against cognitive deterioration (Castro-Alvarez et al., 2011).
Fasudil, Y27632, and other ROCK inhibitors have previously been
proposed as potential treatments for atherosclerosis and vascular
disease (Zhou et al., 2011). Complementarily, we found that Rac
and synaptic adhesion proteins (p120 catenin and N-catenin) are
critical for the recovery from and protection against brain infarc-
tion (Céspedes-Rubio et al., 2010; Gutiérrez-Vargas et al., 2010;
Posada-Duque et al., 2013). Stroke and AD are associated with
altered morphology or loss of dendritic spines (Fiala et al., 2002;
Brown et al., 2008; Li and Murphy, 2008). At the postsynaptic
terminal of an excitatory glutamatergic synapse in the mouse
hippocampus, CDK5 phosphorylates the N-terminal domain
of PSD95 to regulate the synaptic recruitment and clustering
of ion channels, particularly K+ channels and NMDA recep-
tors (NMDARs; Fu et al., 2001; Morabito et al., 2004; Hawasli
et al., 2007). The proteins identified in the postsynaptic density
include cell surface receptors, cytoplasmic signaling enzymes, and
cytoskeletal and scaffold proteins. These proteins include the Rho
GTPases (Jordan et al., 2004; Peng et al., 2004) RhoA, Rac1, and
Cdc42, which regulate the actin cytoskeleton. Actin is the primary
cytoskeletal component of dendritic spines. Accordingly, the Rho
family of GTPases has been implicated in the regulation of den-
dritic spine morphogenesis (Govek et al., 2005; Tada and Sheng,
2006). In particular, RhoA activation exerts a strong inhibitory
effect on spine morphogenesis and causes a profound loss of
spines, in contrast to Rac and Cdc42 activity, which promote
dendritic spine morphogenesis (Govek et al., 2005). p120ctn, a
member of the cadherin/catenin system, regulates Rho GTPases
to modulate actin cytoskeletal remodeling during dendritic spine
formation (Togashi et al., 2002; Elia et al., 2006; Kwiatkowski
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FIGURE 2 | Hypothetical model of the role of the effectors Rho GTPase,
p120 catenin, and CDK5 in the recovery of the structure and function of
the NVU after cerebral ischemia. CDK5 and RhoA/ROCK targeted to ECs,
astrocytes and neurons may exert protection against excitotoxicity and
promote neuronal plasticity and adhesion integrity. Reduction of CDK5
expression in neurons and astrocytes may facilitate synaptic plasticity,
which requires NR2B for LTP and Rac1 and p120 catenin signaling for
dendritic spine morphogenesis and synaptic adhesion. Decreased
expression of CDK5 induces LTP via NR2B (GluN2B)-mediated excitatory
postsynaptic currents, and the consequent induction or accumulation of
p120ctn inhibits RhoA/ROCK, preventing F-actin retraction and inducing
Rac1 activation, thus facilitating neurotransmission. In addition, CDK5
inhibition may prevent tau hyperphosphorylation and facilitate glutamate
uptake in astrocytes, preserve actin remodeling and promote angiogenesis
via eNOS activation. In turn, ROCK inhibition also prevents tau
hyperphosphorylation and dendritic spine retraction and increases the
expression of EAATs to enhance glutamate uptake and promote BBB
integrity. Moreover, actin remodeling induced by Tiam/Rac1 favors stellation
and survival in astrocytes. Likewise, the signaling molecules VE-cadherin
and p120 catenin activate Rac/PI3 kinase and suppress RhoA to maintain
the survival and organization of the actin cytoskeleton, form complexes
with VEGFR-2 to promote BBB adhesion and integrity, and prevent
neutrophil diapedesis. ROCK and CDK5 targeting may promote calcium
wave stimulation via glutamate receptor and PLC/IP3 signaling in astrocytes
to facilitate NO and PGE2 release, thus regulating endothelial vasodilatation
and vasoconstriction.
et al., 2007). p120ctn also regulates spine length via Rho GTPases,
whereas the control of head width requires interactions with
cadherin (Elia et al., 2006; Lee et al., 2008; Ishiyama et al.,
2010). In addition, the postsynaptic membrane contains a high
concentration of NMDARs and associated signaling proteins,
which are assembled via scaffolding proteins into the postsynaptic
density. Excitotoxicity contributes to the pathogenesis of stroke,
and synaptic dysfunction represents an early step in the pathology
of dementia (Kamenetz et al., 2003; Walsh and Selkoe, 2004).
Therefore, based on the aforementioned results and in an effort
to find solutions to health issues, such as cerebral infarction,
these studies suggest that Rho GTPases, p120 catenin, and CDK5
are primary effectors that function in coordination in the recov-
ery of the structure and function of the NVU after cerebral
ischemic infarction in a cell type-specific manner (Figure 2).
These targets act in various neuroprotective contexts, such as
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AD, post-ischemic and excitotoxicity murine models. Treatment
with CDK5 RNAi, roscovitine or atorvastatin improves motor,
cognitive and sensory function in the post-ischemic brain and
triggers neuronal plasticity and survival. The intrinsic plasticity
recovery after stroke, in accordance with the results using injury
models in our previous studies, may suggest that the regulation
of Rho GTPases are associated with actin cytoskeletal remodeling;
p120ctn and synaptic adhesion proteins expression, together with
β-catenin and N-catenin, at post-synapses improve neurotrans-
mission. Therefore, future efforts must focus on individually
targeting the structural and functional roles of each effector and
the interactions in neural (astrocytes, microglia, and neurons)
and non-neural cells (pericytes and ECs) in the post-ischemic
brain and address how to promote the recovery or prevent the
loss of homeostasis in the short, medium and long term.
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